Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS.

Knecht H, Reigl T, Kotrová M, Appelt F, Stewart P, Bystry V, Krejci A, Grioni A, Pal K, Stranska K, Plevova K, Rijntjes J, Songia S, Svatoň M, Froňková E, Bartram J, Scheijen B, Herrmann D, García-Sanz R, Hancock J, Moppett J, van Dongen JJM, Cazzaniga G, Davi F, Groenen PJTA, Hummel M, Macintyre EA, Stamatopoulos K, Trka J, Langerak AW, Gonzalez D, Pott C, Brüggemann M, Darzentas N; EuroClonality-NGS Working Group.

Leukemia. 2019 Jun 21. doi: 10.1038/s41375-019-0499-4. [Epub ahead of print]

PMID:
31227779
2.

Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS.

Scheijen B, Meijers RWJ, Rijntjes J, van der Klift MY, Möbs M, Steinhilber J, Reigl T, van den Brand M, Kotrová M, Ritter JM, Catherwood MA, Stamatopoulos K, Brüggemann M, Davi F, Darzentas N, Pott C, Fend F, Hummel M, Langerak AW, Groenen PJTA; EuroClonality-NGS Working Group.

Leukemia. 2019 Jun 13. doi: 10.1038/s41375-019-0508-7. [Epub ahead of print]

PMID:
31197258
3.

ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data.

Bystry V, Reigl T, Krejci A, Demko M, Hanakova B, Grioni A, Knecht H, Schlitt M, Dreger P, Sellner L, Herrmann D, Pingeon M, Boudjoghra M, Rijntjes J, Pott C, Langerak AW, Groenen PJTA, Davi F, Brüggemann M, Darzentas N; EuroClonality-NGS.

Bioinformatics. 2017 Feb 1;33(3):435-437. doi: 10.1093/bioinformatics/btw634.

PMID:
28172348
4.

Copy number variations as potential diagnostic and prognostic markers for CNS melanocytic neoplasms in neurocutaneous melanosis.

van Engen-van Grunsven AC, Rabold K, Küsters-Vandevelde HV, Rijntjes J, Djafarihamedani M, Hehir-Kwa JY, Küsters B, Willemsen MA, van der Burgt I, Wesseling P, Blokx WA, Groenen PJ.

Acta Neuropathol. 2017 Feb;133(2):333-335. doi: 10.1007/s00401-016-1654-x. Epub 2016 Dec 17. No abstract available.

PMID:
27988846
5.

Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.

van den Brand M, Rijntjes J, Hebeda KM, Menting L, Bregitha CV, Stevens WB, van der Velden WJ, Tops BB, van Krieken JH, Groenen PJ.

Histopathology. 2017 Jan;70(2):174-184. doi: 10.1111/his.13015. Epub 2016 Sep 9.

PMID:
27297871
6.

Immunoglobulin rearrangement analysis from multiple lesions in the same patient using next-generation sequencing.

Appenzeller S, Gilissen C, Rijntjes J, Tops BB, Kastner-van Raaij A, Hebeda KM, Nissen L, Dutilh BE, van Krieken JH, Groenen PJ.

Histopathology. 2015 Dec;67(6):843-58. doi: 10.1111/his.12714. Epub 2015 Jun 26.

PMID:
25891511
7.

Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas.

van Engen-van Grunsven AC, Baar MP, Pfundt R, Rijntjes J, Küsters-Vandevelde HV, Delbecq AL, Keunen JE, Klevering JB, Wesseling P, Blokx WA, Groenen PJ.

Melanoma Res. 2015 Jun;25(3):200-9. doi: 10.1097/CMR.0000000000000152.

PMID:
25756553
8.

Identification of IG-clonality status as a pre-treatment predictor for mortality in patients with immunodeficiency-associated Epstein-Barr virus-related lymphoproliferative disorders.

van der Velden WJ, Nissen L, van Rijn M, Rijntjes J, de Haan A, Venkatraman L, Catherwood M, Liu H, El-Daly H, van de Laar L, Craenmehr MH, van Krieken JH, Stevens WB, Groenen PJ.

Haematologica. 2015 Apr;100(4):e152-4. doi: 10.3324/haematol.2014.116780. Epub 2014 Dec 19. No abstract available.

9.

Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms.

Küsters-Vandevelde HV, van Engen-van Grunsven IA, Coupland SE, Lake SL, Rijntjes J, Pfundt R, Küsters B, Wesseling P, Blokx WA, Groenen PJ.

Pathol Oncol Res. 2015 Apr;21(2):439-47. doi: 10.1007/s12253-014-9841-3. Epub 2014 Oct 15.

PMID:
25315378
10.

NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract--a study of 24 cases from the Netherlands.

van Engen-van Grunsven AC, Küsters-Vandevelde HV, De Hullu J, van Duijn LM, Rijntjes J, Bovée JV, Groenen PJ, Blokx WA.

Gynecol Oncol. 2014 Jul;134(1):10-4. doi: 10.1016/j.ygyno.2014.04.056. Epub 2014 May 5.

PMID:
24802725
11.

Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.

Küsters-Vandevelde HV, Willemsen AE, Groenen PJ, Küsters B, Lammens M, Wesseling P, Djafarihamedani M, Rijntjes J, Delye H, Willemsen MA, van Herpen CM, Blokx WA.

Acta Neuropathol Commun. 2014 Apr 8;2:41. doi: 10.1186/2051-5960-2-41.

12.

Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution.

Boots-Sprenger SH, Sijben A, Rijntjes J, Tops BB, Idema AJ, Rivera AL, Bleeker FE, Gijtenbeek AM, Diefes K, Heathcock L, Aldape KD, Jeuken JW, Wesseling P.

Mod Pathol. 2013 Jul;26(7):922-9. doi: 10.1038/modpathol.2012.166. Epub 2013 Feb 22.

13.

Protein profiling in pathology: analysis and evaluation of 239 frozen tissue biopsies for diagnosis of B-cell lymphomas.

Jansen C, Feuth T, Raemaekers JM, Rijntjes J, Meijer JW, Westenend PJ, van Baarlen J, van Krieken JH, Hebeda KM, Groenen PJ.

Proteomics Clin Appl. 2010 May;4(5):519-27. doi: 10.1002/prca.200900120. Epub 2010 Feb 26.

PMID:
21137069
14.

The nature and timing of specific copy number changes in the course of molecular progression in diffuse gliomas: further elucidation of their genetic "life story".

Jeuken JW, Sijben A, Bleeker FE, Boots-Sprenger SH, Rijntjes J, Gijtenbeek JM, Mueller W, Wesseling P.

Brain Pathol. 2011 May;21(3):308-20. doi: 10.1111/j.1750-3639.2010.00447.x. Epub 2010 Nov 3.

PMID:
21029244
15.

Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics.

Jeuken J, Sijben A, Alenda C, Rijntjes J, Dekkers M, Boots-Sprenger S, McLendon R, Wesseling P.

Brain Pathol. 2009 Oct;19(4):661-71. doi: 10.1111/j.1750-3639.2009.00320.x.

16.

Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma.

van Kempen LC, Rijntjes J, Mamor-Cornelissen I, Vincent-Naulleau S, Gerritsen MJ, Ruiter DJ, van Dijk MC, Geffrotin C, van Muijen GN.

Int J Cancer. 2008 Mar 1;122(5):1019-29.

17.

Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays.

de Wit NJ, Rijntjes J, Diepstra JH, van Kuppevelt TH, Weidle UH, Ruiter DJ, van Muijen GN.

Br J Cancer. 2005 Jun 20;92(12):2249-61.

18.

Type I collagen synthesis parallels the conversion of keratinocytic intraepidermal neoplasia to cutaneous squamous cell carcinoma.

van Kempen LC, Rijntjes J, Claes A, Blokx WA, Gerritsen MJ, Ruiter DJ, van Muijen GN.

J Pathol. 2004 Nov;204(3):333-9.

PMID:
15476275
19.

Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children.

Dorigo-Zetsma JW, Zaat SA, Wertheim-van Dillen PM, Spanjaard L, Rijntjes J, van Waveren G, Jensen JS, Angulo AF, Dankert J.

J Clin Microbiol. 1999 Jan;37(1):14-7.

20.

Supplemental Content

Loading ...
Support Center